1) Methylprednisolone
[英][,meθilpred'nisələun] [美][,mɛθəlprɛd'nɪsə,lon]
甲基强的松龙
1.
High-dose Methylprednisolone Therapy Forty Patients with Graves Oculopathy;
大剂量甲基强的松龙冲击治疗Graves眼病40例
2.
Clinical Observation of Short-Term Systemic Application of Methylprednisolone to Patients with Acute Exacerbation of COPD;
慢性阻塞性肺疾病急性加重期短期使用甲基强的松龙疗效观察
3.
Therapy of Methylprednisolone in Asthma on Acute Episode;
甲基强的松龙治疗哮喘急性发作的临床观察
2) Methylprednisolone (MP)
甲基强的松龙
1.
ObjectiveTo investigate the expression of pro inflammatory cytokine mRNA including interleukin 1β (IL 1β), interleukin 6 (IL 6) and tumor necrosis factor α (TNF α) after spinal cord injury (SCI), and the effect of methylprednisolone (MP) on the expression of the cytokine and neurological outcome after SCI in rats.
目的 观察大鼠脊髓损伤(SCI)后,甲基强的松龙(MP)对炎症性细胞因子白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α) mRNA表达及运动功能恢复的影响。
2.
Methylprednisolone (MP) has been comprehesive studied on the spin.
甲基强的松龙(Methylprednisolone MP)对于急性脊髓损伤的治疗已有广泛的研究,但对于能否减轻或避免在椎板减压术后出现的脊髓再灌注损伤尚缺乏临床的观察研究资料。
3) medron
甲基强的松龙
1.
Analysis of high dose human gamma globulin in combination in medron therapy for children with acute Guillian-Barre syndrome;
免疫球蛋白联合甲基强的松龙治疗急性格林巴利综合征疗效观察
2.
The analysis of high-dose human gamma globulin in combination in medron therapy for twenty children with acute Guillian-Barr e syndrome;
大剂量免疫球蛋白联合甲基强的松龙治疗格林-巴利综合征20例
3.
Conclusion:Medron impact treatment has good effect on severe drug eruption.
目的:探讨甲基强的松龙冲击治疗重症药疹的临床效果。
4) 6α-Methylprednisolone
6α-甲基强的松龙
1.
The Synthesis of 6α-Methylprednisolone by Chemical Reaction and Microbial Biotransformation;
6α-甲基强的松龙生产工艺开发
5) methylprednisolone(MP)
甲强的松龙
6) Metrisone
甲基强的松龙注射剂
1.
Effect and ADRs of Metrisone Administration Occasion Dosage to Critical Patients with Severe Acute Respiratory Syndrome;
重症SARS患者应用甲基强的松龙注射剂时机对疗效和不良反应影响
2.
METHODS: The information of the medications in 680 patients with severe acute respiratory syndrome (SARS) in Xiaotangshan Hospital was collected by HIS system and the effects and ADRs of metrisone were staiated.
目的 :了解应用甲基强的松龙注射剂SARS患者的病情、治疗情况和不良反应。
补充资料：甲基强的松龙
分子式：C22H30O5
分子量：暂无
CAS号：83-43-2
性质：暂无
制备方法：暂无
用途：适用于风湿性关节炎、胶原病、过敏性疾病、眼科疾患、淋巴白血病、软组织炎症及溶血性贫血等。
分子量：暂无
CAS号：83-43-2
性质：暂无
制备方法：暂无
用途：适用于风湿性关节炎、胶原病、过敏性疾病、眼科疾患、淋巴白血病、软组织炎症及溶血性贫血等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条